Dichlorodiphenyltrichloroethane (DDT) and its metabolites (DDTs), such as dichlorodiphenyldichloroethylene (DDE) and dichlorodiphenyldichloroethane (DDD), are synthetic organochlorine pesticides with long environmental persistence. Although DDT has been phased out in many countries, DDE and DDD remain prevalent worldwide. Growing evidence links DDTs exposure to Alzheimer's disease (AD), though underlying molecular targets and mechanisms remain unclear.
Objective
In this study, we investigated molecular targets and pathways through which DDTs potentially induce AD using network toxicology combined with molecular docking techniques.
Methods
AD-related targets associated with DDTs were identified through bioinformatics searches. Key targets were selected via STRING protein-protein interaction analysis and Cytoscape, followed by signaling pathway enrichment analysis. Diagnostic efficacy was evaluated using ROC curve analysis and nomogram modeling based on GEO datasets. Molecular docking validated binding affinity between DDTs and core target proteins predicted by AlphaFold 3.
Results
We identified 1732 potential molecular targets linking DDTs exposure to AD. Pathway analysis revealed DDTs predominantly affect AD pathogenesis by modulating apoptosis, p53 signaling, TNF signaling, and IL-17 signaling pathways. STRING and Cytoscape analyses identified seven core targets. GEO dataset validation indicated RPL23, RPS6, and RPS8 as pivotal targets, with RPL23 having strongest predictive capacity. Molecular docking confirmed binding interactions between DDTs and RPL23, with binding energies of −7.2 kcal mol−1 for DDT, −6.5 kcal mol−1 for DDE, and −7.1 kcal mol−1 for DDD.
Conclusions
This research provides novel insights into neurotoxic mechanisms of DDT and its persistent metabolites DDE and DDD, and supports enhanced public health strategies for AD prevention.
MatsushimaA. A novel action of endocrine-disrupting chemicals on wildlife; DDT and its derivatives have remained in the environment. Int J Mol Sci2018; 19: 1377.
2.
FengWLWuJPLiX, et al.Bioaccumulation and maternal transfer of two understudied DDT metabolites in wild fish species. Sci Total Environ2022; 818: 151814.
3.
HellouJLebeufMRudiM. Review on DDT and metabolites in birds and mammals of aquatic ecosystems. Environ Rev2013; 21: 53–69.
4.
MansouriACregutMAbbesC, et al.The environmental issues of DDT pollution and bioremediation: a multidisciplinary review. Appl Biochem Biotechnol2017; 181: 309–339.
5.
LiJChangRWBanXY, et al.Primary emissions or environmental persistence contribute to the present DDTs: evidence from sediment records in Tibetan lakes. J Hazard Mater2023; 459: 132342.
6.
MengistuDAGeremewATessemaRA, et al.Concentrations of DDT metabolites in different food items and public health risk in Africa regions: systematic review and metal analysis. Front Public Health2025; 13: 1511012.
7.
NfonECousinsITBromanD. Biomagnification of organic pollutants in benthic and pelagic marine food chains from the Baltic Sea. Sci Total Environ2008; 397: 190–204.
8.
FoordCSRobbKNugegodaD. Legacy organic pollutants are still a threat for resident dolphins of south-east Australia. Environ Res2025; 270: 121045.
9.
BeardJ. Australian rural health research collaboration DDT and human health. Sci Total Environ2006; 355: 78–89.
10.
RichardsonJRRoyAShalatSL, et al.Elevated serum pesticide levels and risk for Alzheimer disease. JAMA Neurol2014; 71: 284–290.
11.
SugandhiVVGadhaveDGUgaleAR, et al.Advances in Alzheimer's therapy: exploring neuropathological mechanisms to revolutionize the future therapeutic landscape. Ageing Res Rev2025; 109: 102775.
12.
MertaşBBoşgelmezIİ. The role of genetic, environmental, and dietary factors in Alzheimer's disease: a narrative review. Int J Mol Sci2025; 26: 1222.
13.
EidAMhatre-WintersISammouraFM, et al.Effects of DDT on amyloid precursor protein levels and amyloid beta pathology: mechanistic links to Alzheimer's disease risk. Environ Health Perspect2022; 130: 87005.
14.
ChengMHLiMNZhangYM, et al.Exploring the mechanism of PPCPs on human metabolic diseases based on network toxicology and molecular docking. Environ Int2025; 196: 109324.
15.
AbramsonJAdlerJDungerJ, et al.Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature2024; 630: 493–500.
16.
SukumaranSZochedhAChandranK, et al.Exploring the co-activity of FDA approved drug gemcitabine and docetaxel for enhanced anti-breast cancer activity: DFT, docking, molecular dynamics simulation and pharmacophore studies. Int J Quantum Chem2024; 124: e27359.
17.
StanzioneFGiangrecoIColeJC. Use of molecular docking computational tools in drug discovery. Prog Med Chem2021; 60: 273–343.
18.
BanerjeePKemmlerEDunkelM, et al.Protox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res2024; 52: W513–W520.
19.
DainaAMichielinOZoeteV. Swisstargetprediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res2019; 47: W357–W364.
20.
GaultonABellisLJBentoAP, et al.ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res2012; 40: D1100–D1107.
UniProtC. Uniprot: a worldwide hub of protein knowledge. Nucleic Acids Res2019; 47: D506–D515.
23.
Dennis Jr.GShermanBTHosackDA, et al.DAVID: database for annotation, visualization, and integrated discovery. Genome Biol2003; 4: P3.
24.
SafranMDalahIAlexanderJ, et al.Genecards Version 3: the human gene integrator. Database (Oxford)2010; 2010: baq020.
25.
von MeringCHuynenMJaeggiD, et al.STRING: a database of predicted functional associations between proteins. Nucleic Acids Res2003; 31: 258–261.
26.
LiuYGrimmMDaiWT, et al.CB-Dock: a web server for cavity detection-guided protein-ligand blind docking. Acta Pharmacol Sin2020; 41: 138–144.
27.
EricksonMABanksWA. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab2013; 33: 1500–1513.
28.
TurusovVRakitskyVTomatisL. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environ Health Perspect2002; 110: 125–128.
29.
KodaliJPavuluriSArunrajB, et al.Tapping the potential of a glucosamine polysaccharide-diatomaceous earth hybrid adsorbent in the solid phase extraction of a persistent organic pollutant and toxic pesticide 4,4′-DDT from water. Rsc Adv2022; 12: 5489–5500.
30.
ZhangCLeiYQianJ, et al.Sorption of organochlorine pesticides on polyethylene microplastics in soil suspension. Ecotoxicol Environ Saf2021; 223: 112591.
31.
OgataYTakadaHMizukawaK, et al.International Pellet Watch: global monitoring of persistent organic pollutants (POPs) in coastal waters. 1. Initial phase data on PCBs, DDTs, and HCHs. Mar Pollut Bull2009; 58: 1437–1446.
32.
CaoZLuYYangQ, et al.Mapping the hidden journey of microplastics: multi-organ deposition patterns and organ-specific health risks revealed by AI-driven analysis. Innovation2025; 6: 101031.
33.
KaliaVNiedzwieckiMMBradnerJM, et al.Cross-species metabolomic analysis of tau- and DDT-related toxicity. PNAS Nexus2022; 1: pgac050.
34.
LiGKimCKimJ, et al.Common pesticide, dichlorodiphenyltrichloroethane (DDT), increases amyloid-beta levels by impairing the function of ABCA1 and IDE: implication for Alzheimer's disease. J Alzheimers Dis2015; 46: 109–122.
35.
EskenaziBChevrierJRosasLG, et al.The Pine River statement: human health consequences of DDT use. Environ Health Perspect2009; 117: 1359–1367.
CrinnionWJ. The CDC Fourth National Report on Human Exposure to Environmental Chemicals: what it tells us about our toxic burden and how it assists environmental medicine physicians. Altern Med Rev2010; 15: 101–109.
38.
KumariSDhapolaRReddyDH. Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues. Apoptosis2023; 28: 943–957.
39.
SharmaVKSinghTGSinghS, et al.Apoptotic pathways and Alzheimer's disease: probing therapeutic potential. Neurochem Res2021; 46: 3103–3122.
40.
WanLYangFYinA, et al.Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer's disease. Cell Death Differ2025; 32: 837–854.
41.
JembrekMJNewbergKŠimićG. The role of p53 in Alzheimer’s disease: impact on tau pathology. In: SinghSJoshiN (eds) Pathology, prevention and therapeutics of neurodegenerative disease. Singapore: Springer Singapore, 2019, pp.39–48.
42.
WangH-HLiH-LLiuR, et al.Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors. J Alzheimers Dis2010; 21: 167–179.
43.
ZhengCZhouX-WWangJ-Z. The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ. Transl Neurodegener2016; 5: 7.
44.
BrigasHCRibeiroMCoelhoJE, et al.IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer’s disease. Cell Rep2021; 36: 109574.
45.
El KhouryWNasrZ. Deregulation of ribosomal proteins in human cancers. Biosci Rep2021; 41: BSR20211577.
46.
DingQMarkesberyWRChenQ, et al.Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci2005; 25: 9171–9175.
47.
RimalSLiYVartakR, et al.Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease. Acta Neuropathol Commun2021; 9: 1–24.
48.
EvansHTBenetatosJvan RoijenM, et al.Decreased synthesis of ribosomal proteins in tauopathy revealed by non-canonical amino acid labelling. EMBO J2019; 38: e101174.
49.
GaoYZhuYSunQ, et al.Ribosome-associated protein quality control: implications for neurodegenerative diseases and therapeutic potential. Sci Bull2024; 69: 1165–1169.
50.
Alavi NainiSMSoussi-YanicostasN. Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies?Oxid Med Cell Longev2015; 2015: 151979.
51.
EvansHTTaylorDKneynsbergA, et al.Altered ribosomal function and protein synthesis caused by tau. Acta Neuropathol Commun2021; 9: 110.
52.
Hernandez-OrtegaKGarcia-EsparciaPGilL, et al.Altered machinery of protein synthesis in Alzheimer's: from the nucleolus to the ribosome. Brain Pathol2016; 26: 593–605.
53.
YamakawaASuganumaMMitsumoriR, et al.Author correction: Alzheimer's disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function. Sci Rep2025; 15: 8672.
54.
WillettJDSWaqasMChoiY, et al.Identification of 16 novel Alzheimer's disease loci using multi-ancestry meta-analyses. Alzheimers Dement2025; 21: e14592.
